Mersana Therapeutics
MRSN
#8913
Rank
โ‚ฌ0.11 B
Marketcap
23,94ย โ‚ฌ
Share price
-0.85%
Change (1 day)
-60.36%
Change (1 year)

Earnings for Mersana Therapeutics (MRSN)

Earnings in 2025 (TTM): -โ‚ฌ66.43 Million

According to Mersana Therapeutics's latest financial reports the company's current earnings are โ‚ฌ34.76 Million. In 2024 the company made an earning of -โ‚ฌ59.03 Million, an increase over its 2023 earnings that were of -โ‚ฌ0.15 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Mersana Therapeutics from 2016 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -โ‚ฌ66.43 Million12.55%
2024 -โ‚ฌ59.03 Million-59.94%
2023 -โ‚ฌ0.15 Billion-15.94%
2022 -โ‚ฌ0.18 Billion20.08%
2021 -โ‚ฌ0.15 Billion93.16%
2020 -โ‚ฌ75.56 Million212.12%
2019 -โ‚ฌ24.21 Million-56.1%
2018 -โ‚ฌ55.15 Million66.02%
2017 -โ‚ฌ33.22 Million182.53%
2016 -โ‚ฌ11.76 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ORIC Pharmaceuticals
ORIC
-โ‚ฌ0.13 Billion 101.07%๐Ÿ‡บ๐Ÿ‡ธ USA